Microbicides in India-present and future.
India continues to wage a battle against the human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) epidemic. Despite an array of preventive and control efforts directed against the disease, it continues to finds its way from the high risk groups to the general population. Women are more vulnerable to HIV/AIDS because of biological as well as socio-cultural factors. Microbicides appear to provide an attractive option as a means of protection to be used by women. At present, microbicide trials are in study phases I and II in India. The development of an ideal microbicide candidate which would be effective and confirms to user satisfaction poses a major challenge to researchers.
Nath
A
A
Centre for Biomedical Research, Population Council, New York City, NY 10065, USA. anath@popcouncil.org
Garg
S
S
D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology* / Q000517:prevention & control*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D018890:Chemoprevention / Q000379:methods*; D002986:Clinical Trials as Topic; D005260:Female; D006678:HIV / Q000187:drug effects; D006801:Humans; D007194:India; D008297:Male
D000890:Anti-Infective Agents